These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7330905)

  • 1. [Radiotherapeutic results in case of malignant ovarian tumors with special consideration of stage Ia (author's transl)].
    Hackl A; Schneider GH
    Strahlentherapie; 1981 Dec; 157(12):780-5. PubMed ID: 7330905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical manifestations and therapy of dysgerminomas (author's transl)].
    Bamberg M; Schultz U; Scherer E
    Strahlentherapie; 1981 May; 157(5):290-6. PubMed ID: 7245273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prognosis of malignant ovarian tumours in correlation to the histological findings (author's transl)].
    Sievers S; Dallenbach-Hellweg G; Susemihl D; Pohl R
    Geburtshilfe Frauenheilkd; 1981 Jan; 41(1):10-4. PubMed ID: 7202985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?
    Skirnisdottir I; Nordqvist S; Sorbe B
    Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of operation and irradiation in 683 cases with ovarian carcinoma (author's transl)].
    Kucera H; Szalay S; Weghaupt K
    Strahlentherapie; 1980 Dec; 156(12):845-50. PubMed ID: 6779406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities for operative therapy of carcinoma of the large intestine (author's transl)].
    Bokelmann D
    MMW Munch Med Wochenschr; 1977 May; 119(18):623-8. PubMed ID: 69266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of risk factors for epithelial ovarian cancer recurrence].
    Liu S; Liu JH; Huang H; Peng XP; Wang YM
    Ai Zheng; 2003 Nov; 22(11):1197-200. PubMed ID: 14613652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms.
    Sainz de la Cuesta R; Goff BA; Fuller AF; Nikrui N; Eichhorn JH; Rice LW
    Obstet Gynecol; 1994 Jul; 84(1):1-7. PubMed ID: 8008300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant ovarian neoplasms in young women (author's transl)].
    Kubista E; Kucera H; Kupka S
    Geburtshilfe Frauenheilkd; 1975 Nov; 35(11):872-7. PubMed ID: 1193359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant mixed mesodermal tumors of the ovary: a clinical analysis of 12 cases].
    Li H; Shi S; Zhang W
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):460-2. PubMed ID: 10920946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of fertility preserving operations in malignant ovarian tumors].
    Kleine W
    Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The problems of prophylactic chemotherapy, the second-look operation and the maintenance of the remission in the treatment of ovarian cancer (author's transl)].
    Pfleiderer A
    Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):132-9. PubMed ID: 1254157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis and therapy in case of hypopharynx carcinoma (author's transl)].
    Richter E
    Strahlentherapie; 1981 Jul; 157(7):446-9. PubMed ID: 7268815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence and prognostic factors in borderline ovarian tumors.
    Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
    Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
    Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.